Pet Partners and the Baxter Foundation Expand Therapy Animal Programs to Support 100,000 Patients and Healthcare Workers in Two-Year Pilot
Rhea-AI Summary
Pet Partners and the Baxter Foundation (NYSE:BAX) launched a two-year pilot to expand therapy animal visits in U.S. healthcare settings, targeting 100,000 patients and healthcare workers. The pilot covers Northern California, Upstate New York and Greater Chicago and funds training, safety updates, research, volunteer recruitment and employee engagement.
The initiative aims to reduce stress and improve resilience for patients and care teams by scaling evidence-based animal-assisted interventions.
Positive
- 100,000 people targeted over two years
- Pilot covers three regions: Northern California, Upstate New York, Greater Chicago
- Funding for training and safety updates for therapy visits
- Planned research study on impact for healthcare professionals
- Baxter employee engagement opportunities to support volunteering
Negative
- Program limited to three regions during the two-year pilot
News Market Reaction – BAX
On the day this news was published, BAX gained 2.39%, reflecting a moderate positive market reaction.
Data tracked by StockTitan Argus on the day of publication.
Key Figures
Market Reality Check
Peers on Argus
BAX was up 0.66% with peers like SOLV, HOLX, COO, WST and BDX also posting small gains (up to 2.6%). However, no peers appeared in the momentum scanner, and sector-wide momentum was not flagged.
Historical Context
| Date | Event | Sentiment | Move | Catalyst |
|---|---|---|---|---|
| Mar 16 | CFO transition | Neutral | -0.8% | Executive leadership change with interim CFO and outlook reaffirmation. |
| Feb 12 | Earnings release | Negative | -16.0% | Q4 2025 loss, goodwill impairment, and down 24% adjusted EPS. |
| Jan 21 | Earnings call notice | Neutral | +1.8% | Announcement of Q4 2025 investor call scheduling and access details. |
| Jan 13 | Product launch | Positive | -2.5% | Launch of Dynamo Series smart stretcher for hospital care settings. |
| Jan 8 | Strategic partnership | Positive | +1.4% | Multi-year technology partnership with MUSC Health to enhance bedside care. |
Recent fundamental and governance news has mostly seen price reactions aligned with the underlying sentiment, with one notable divergence on a product launch.
Over recent months, Baxter’s news flow has centered on portfolio refinement, governance change and product innovation. Earnings on Feb 12, 2026 showed a GAAP loss and lower adjusted EPS, drawing a -15.99% reaction. A CFO transition on Mar 16 and multiple governance-focused filings framed a broader leadership transition. Product and partnership updates, such as the Dynamo Series launch and the MUSC Health collaboration in January 2026, highlighted efforts to modernize bedside care. Today’s therapy-animal partnership fits into this theme of patient and caregiver support.
Market Pulse Summary
This announcement details a two-year pilot between Baxter’s foundation and Pet Partners to bring therapy animals to as many as 100,000 patients and healthcare professionals. It reinforces Baxter’s positioning around caregiver support and hospital resilience, complementing earlier partnerships and bedside-technology launches. Investors may watch how such initiatives integrate with broader strategy, governance changes, and recent financial trends, as well as any data emerging from the planned study on healthcare worker outcomes.
Key Terms
therapy animal medical
animal-assisted interventions medical
infusion pump medical
AI-generated analysis. Not financial advice.
Largest Single Investment from a Corporate Foundation Aims to Strengthen Healthcare Resilience by Advancing Therapy Animal Visits in
As healthcare workers grapple with high levels of stress and burnout, while patients and their families cope with the emotional challenges of treatment, therapy animals can help provide much-needed moments of calm, connection and comfort. Research shows that interactions with therapy animals can lead to lower pain ratings for patients, as well as reduced [i]anxiety and depression. And for healthcare workers, even brief, five-minute therapy dog visits have been shown to lower stress, anxiety[ii]s. Yet, many healthcare facilities lack the administrative support and volunteer base needed to develop and sustain animal therapy programs. Together, Pet Partners and the Baxter Foundation aim to provide resources, training and infrastructure to help more healthcare settings integrate therapy animal visits into their care practices.
"Our collaboration with Pet Partners was inspired by the story of a young patient named Izzy who welcomed a dog into her life during her cancer treatment and named him Baxter – after the Baxter infusion pump that supported her chemotherapy," said Stacey Eisen, Baxter's chief communications officer and president of the Baxter Foundation. "Hearing how much comfort Baxter [the dog] brought Izzy and her family was a powerful reminder of how healing the human-animal bond can be during incredibly challenging moments. At Baxter, we support patients and care teams every day through our products and services, and this partnership allows us to extend that support at the bedside and across the hospital in a new and deeply meaningful way."
The Baxter Foundation's investment will support Pet Partners with the following objectives:
- Expand access to therapy animals: Bring therapy animals to more patients and healthcare workers by increasing visits to healthcare settings and recruiting more Pet Partners volunteers.
- Advance animal-assisted interventions: Support volunteer education and training to ensure safe, evidence-based therapy animal visits, including updating Pet Partners' safety and infection control course.
- Strengthen industry research: Conduct a study on the impact of therapy animals on healthcare professionals to expand public and professional understanding of animals' roles in supporting a more resilient healthcare system.
- Engage Baxter employees: Provide hands-on opportunities for Baxter employees to get involved through volunteering, workplace well-being events and more.
"We are thrilled to partner with the Baxter Foundation to expand access to therapy animals and deepen the impact of animal-assisted interventions in healthcare," said Annie Peters, CEO of Pet Partners. "Together, we are creating meaningful moments that support resilience for healthcare workers and comfort for patients. This partnership represents an exciting step forward in advancing the human–animal bond in healthcare settings nationwide."
The initial two-year pilot is officially underway. Visit www.petpartners.org/baxter to learn more.
About Pet Partners
Pet Partners is the leader in the therapy animal field for registering volunteer teams. Since 1977, we have supported thousands of teams in making millions of meaningful visits across the country and around the world. Through the human-animal bond, we can improve the physical, social, and emotional lives of both the people and animals involved. Pet Partners supports volunteer teams by offering the highest quality preparation, an unmatched approach to evaluation and registration—for nine different types of animals—and a focus on connections. We elevate the importance of therapy animal visits, and our teams help build a healthier and happier world for us all. Whether or not you have a pet, learn more about sharing the human-animal bond by visiting petpartners.org.
About the Baxter Foundation
Every day, Baxter and the Baxter Foundation strive to make a meaningful difference in the lives of people who depend on our products, and in the communities where our employees live and work. The Foundation helps advance Baxter's Mission to Save and Sustain Lives by partnering with organizations around the world to increase access to healthcare for the underserved, develop the next generation of innovators who will lead the way in advancing healthcare and create a positive, long-lasting impact in communities globally. For more information, please visit Baxter's Corporate Responsibility page.
Baxter is a registered trademark of Baxter International Inc. or its subsidiaries.
i Carey, Ben, et al., 2022, PLOS One
ii Kline et al., 2020, Academic Emergency Medicine
View original content to download multimedia:https://www.prnewswire.com/news-releases/pet-partners-and-the-baxter-foundation-expand-therapy-animal-programs-to-support-100-000-patients-and-healthcare-workers-in-two-year-pilot-302724420.html
SOURCE Pet Partners
FAQ
What is the scope of the Pet Partners and Baxter Foundation pilot for therapy animals (BAX) in 2026?
How will the Baxter Foundation's investment support therapy animal programs tied to BAX?
When did the Pet Partners and Baxter Foundation partnership begin and what is its timeline?
Which regions will the therapy animal pilot (BAX) prioritize during the two-year program?
Will the pilot include research on therapy animals' impact on healthcare workers funded by BAX?
How can Baxter employees participate in the Pet Partners program supported by the Baxter Foundation?
